BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
8.6300
10-February-25 16:45:00
15 minutes delayed
Stocks
-0.0900
-1.03%
Today's range
8.5300 - 8.8000
ISIN
N/A
Source
NASDAQ
-
BioCryst to Present at Upcoming Investor Conferences
07 May 2024 07:00:22 By Nasdaq GlobeNewswire
-
BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
06 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 May 2024 07:00:07 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
25 Apr 2024 09:45:08 By NetDania Notify
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
24 Apr 2024 09:54:30 By NetDania Notify
-
BioCryst to Report First Quarter 2024 Financial Results on May 6
22 Apr 2024 07:00:50 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
19 Apr 2024 11:04:56 By NetDania Notify
-
BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency
17 Apr 2024 04:30:39 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
05 Apr 2024 09:45:07 By NetDania Notify
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
04 Apr 2024 15:51:53 By NetDania Notify
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
03 Apr 2024 09:45:12 By NetDania Notify
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Apr 2024 07:00:23 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
02 Apr 2024 12:00:22 By NetDania Notify
-
BioCryst to Present at Upcoming Investor Conferences
25 Mar 2024 16:01:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
14 Mar 2024 13:48:51 By NetDania Notify
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Mar 2024 07:01:47 By Nasdaq GlobeNewswire
-
BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones
26 Feb 2024 07:00:05 By Nasdaq GlobeNewswire
-
23 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
21 Feb 2024 16:01:58 By Nasdaq GlobeNewswire
-
BioCryst Launches ORLADEYO® (berotralstat) in Italy
19 Feb 2024 07:54:52 By Nasdaq GlobeNewswire